3138 results for «3164»
3138 results
SURTAVI five-year outcomes - What do you need to know considering the new ESC guidelines?
21 Nov 2021 – From PCR London Valves 2021
Join Nicolas Van Mieghem, Nicole Karam and Thomas Modine to learn more about about SURTAVI five-year study outcomes and to discover which factors are impacting valve performance overtime.
Cusp overlap technique - How it evolved my practice?
21 Nov 2021 – From PCR London Valves 2021
Join Darren Mylotte, Derk Frank and Vincent Roolvink if you want to discover real-life practices with the Cusp Overlap technique, as well as to learn about its adoption benefits and its essentials procedural steps.
Lean TAVI: safe efficiencies and better economics
21 Nov 2021 – From PCR London Valves 2021
Join Dider Tchétché and Stefan Toggweiler if you want to learn about the Lean TAVI practice and the Lucerne study results, the Lean TAVI adoption at other centres / Heart Teams, as well as the procedural efficiencies and their importance in the success of the overall...
The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in clinical practice
21 Nov 2021 – From PCR London Valves 2021
Join Raúl Moreno, Julian Widder and Mathias Wolfrum if you want to learn about a single-centre experience of their first 100 patients treated with the ALLEGRA, and to see clinical outcome data on over 250 cases treated with ALLEGRA from a European multicentre registry.
Outcomes after novel transcatheter and surgical tricuspid valve interventions
21 Nov 2021 – From PCR London Valves 2021
Find out more about TRI-SCORE, a new risk score to predict in-hospital mortality after isolated tricuspid valve surgery, 30-day outcomes for transcatheter tricuspid repair from the TriBAND study, both the CLASP TR early feasibility and TRISCEND studies six-month results, and more in this PCR London Valves...
Is image fusion needed or too complex for standard transcatheter edge-to-edge repair?
21 Nov 2021 – From PCR London Valves 2021
Join Covadonga Fernandez-Golfin, Roberto Corti and Patric Biaggi if you want to learn about the benefits of image fusion and discover some tips and tricks on how to make image fusion easy and not complex in transcatheter edge-to-edge-repair.
Outcomes following transcatheter and percutaneous mitral valve repair
21 Nov 2021 – From PCR London Valves 2021
CLASP study, predictability of post-delivery residual mitral regurgitation, MiCLASP PMCF study, off-pump transapical neochord implantation, pronostic impact of nutritional status, and patients with low, intermediate and high frailty are the focus of this session from PCR LV 2021 devoted to percutaneous and transcatheter mitral valve repair.
Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis
21 Nov 2021 – From PCR London Valves 2021
Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.
EAPCI: patient initiatives around the world
22 Nov 2021 – From PCR London Valves 2021
In this session, you can find out more about the EAPCI Valve for Life initiative and what progress has been made in selected countries, as well as other collaborative initiatives across the world.
Transcatheter mitral, aortic and pulmonary valve implantation
21 Nov 2021 – From PCR London Valves 2021
Watch this series of videos from PCR London Valves 2021 to learn about acute heart failure hospitalizations following TAVI in the U.S., share a peripheral hospital's experiences with structural valve service modernization, enjoy percutaneous transseptal mitral valve implantation in Brazil, and more!
Miscellaneous - Paravalvular leak closure, PFO closure and LAA occlusion
21 Nov 2021 – From PCR London Valves 2021
Want to know more about the impact of baseline PFO anatomy on residual right to left shunt after transcatheter closure, transcatheter closure of paravalvular leak, or even percutaneous mitral paravalvular leak closure using CT planning? This PCR London Valves 2021 session is for you!
PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI
21 Nov 2021 – From PCR London Valves
Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.
Periprocedural outcomes of MANTA vascular closure device used in large-bore arterial access following VARC-3 definitions. More scientific evidence behind plug-based vascular closure device
21 Nov 2021 – From PCR London Valves 2021
Join Simon Redwood, Radoslaw Parma and Nicolas Van Mieghem if you want to learn about the results of the latest 120 patient MANTA registry, the best practices comparing to similar registries of the past, as well as tips and tricks on how to use MANTA vascular...
Valve-in-valve TAVI
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on valve-in-valve TAVI to learn how to identify patient at risk of coronary obstruction and PPM post VIV procedure, and discover how to protect the coronary arteries and how to minimise PPM during the surgery.
A patient with LAD-diagonal bifurcation lesion
22 May 2019 – From EuroPCR 2019
Opening - LIVE demonstration from National University Heart Centre Singapore
04 Jul 2019 – From AICT-AsiaPCR 2019
Complex distal left main bifurcation lesion
04 Jul 2019 – From AICT-AsiaPCR 2019
A 75-year-old male with multiple risk factors and a history of NSTEMI is admitted for staged PCI to his left main bifurcation. His vessels are diffusely calcified…
AICT-AsiaPCR Opening Ceremony
04 Jul 2019 – From AICT-AsiaPCR 2019
Consult this session to watch AICT-AsiaPCR 2019 Opening Ceremony, led by Jean Fajadet. Discover the missions of PCR, and the novelties offered by the AICT-AsiaPCR course, arising from the Asia-Pacific region and showcasing its clinical research and innovations.
Calcified lesions
05 Jul 2019 – From AICT-AsiaPCR 2019
Watch this LIVE demonstration from National University Heart Centre (Singapore) to discover how they managed the case of a 69 years-old male with diabetes, hypertension and hyperlipidemia suffering from a calcified triple vessel disease.
Diffuse multivessel disease
05 Jul 2019 – From AICT-AsiaPCR 2019
